semaglutide gi obstruction attorney in west virginia law firm Wegovy Lawsuit San Diego Ozempic Lawsuits semaglutide digestive blockage attorney in

It is estimated that the glucagon-like peptide-1 (GLP-1) market will exceed US$100 billion (80.3 billion) by 2030, driven equally by diabetes and obesity usage

Originally created to help people living with type 2 diabetes, drugs like Zepbound and Wegovy have skyrocketed in popularity for their powerful effects on weight loss

The risk of pancreatitis with GLP-1 agonist medications is well-documented, though the incidence remains very low (0.27% to 2.2%, depending on the study)

Thermo Fisher Scientific, Cat#A-11034)

A person with mild, occasional symptoms may only need to adjust water and fiber intake, while someone with symptoms lasting more than a week may need guidance from their provider on next steps